HIRSCHMAN ORIN 4/A
4/A · Ohr Pharmaceutical Inc · Filed Dec 6, 2017
Insider Transaction Report
Form 4/AAmended
HIRSCHMAN ORIN
Director10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2017-04-10$0.70/sh+171,429$120,000→ 1,678,177 total(indirect: By LLC) - Purchase
Warrants (right to buy)
2017-04-10+120,001→ 120,001 totalExercise: $1.00From: 2017-04-10Exp: 2022-04-10→ Common Stock (120,001 underlying)
Holdings
- 138,200(indirect: By Children)
Common Stock, par value $0.0001 per share
Footnotes (1)
- [F1]On April 5, 2017, Ohr Pharmaceutical, Inc. (the "Issuer") entered into a securities purchase agreement (the "Securities Purchase Agreement") with various purchasers set forth on the signatures pages thereto, including the Reporting Person. Pursuant to the Securities Purchase Agreement, the Reporting Person purchased shares of the Issuer's common stock (the "Common Stock") and warrants to purchase shares of Common Stock in a registered offering (the "Offering") for an aggregate purchase price of $120,000. The closing of the Offering occurred on April 10, 2017. The form 4 as originally filed underreported the Reporting Person's investment by $20,000, shares of common stock by 28,571, and shares of common stock issuable upon exercise of warrants by 20,000.